Santen launches Ducressa for post-cataract surgery
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery
Read More
Author: John Pinching
MHRA authorises Moderna’s omicron-containing bivalent booster
Study results show the candidate has demonstrated significantly higher antibodies against Omicron
Read More
NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status
Read More
MHRA grants marketing authorisation for Novartis’ Pluvicto
Radioligand therapy involves patients with advanced prostate cancer in Great Britain
Read More
Medicines Discovery Catapult and Zeiss join forces
Partnership will focus on driving the application of microscopy in drug discovery
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
